Evaluation of selected interleukins, tumor necrosis factor, insulin and leptin in obese patients with hypertension;Ocena stȩżenia wybranych interleukin, czynnika martwicy nowotworów, insulinemii i leptynemii u otyłych z nadciśnieniem tȩtniczym

Polski Merkuriusz Lekarski

Volumn 15, Issue 88, 2003, Pages 347-351

  Bogdański, Paweł ^a,b   Kujawska Łuczak, Magdalena ^a   Ła̧cki, Jan ^a   Pupek Musialik, Danuta ^a   Januszewicz, Włodzimierz ^a   Manitius, Jacek ^a   Łuczak, Magdalena ^a   Czekalski, Stanisław ^a   Nartowicz, Edmund ^a   Hruby, Zbigniew ^a  

^a AM ^*

^b Katedra i Klinika Chorob Wewnetrznych   (Poland)

Author keywords

Hypertension; Inflammation; Insulin resistance; Obesity

Indexed keywords

CYTOKINE; GLUCOSE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN DERIVATIVE;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE MARKER; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; MALE; OBESITY; SYSTOLIC BLOOD PRESSURE; ANTHROPOMETRY; ARTICLE; METABOLISM; MIDDLE AGED;

ANTHROPOMETRY; FEMALE; HUMANS; HYPERTENSION; INSULIN; INTERLEUKINS; LEPTIN; MALE; MIDDLE AGED; OBESITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 17144447388     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Agata J., Masuda A., Takada M.: High plasma immunoreactive leptin level in essential hypertension. Am. J. Hypertens., 1997, 10, 1171-1174.
2. Chae C. i wsp.: Blood pressure and inflammation in apparently healthy men. Hypertension, 2001, 38, 399.
3. Gokhan S. i wsp.: Adipose expression of tumor necrosis factor-a: direct role in obesity-linked insulin resistance. Science, 1993, 259, 87-90.
4. Hotamisligil G. i wsp.: Increased adipose expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest., 1995, 95, 2409-2415,
5. Kannel W. i wsp.: The relation of adiposity to blood pressure and development of hypertension: the Framingham study. Ann. Int. Med., 1967, 67, 48-59.
6. Kern P. i wsp.: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol., 2001, 280, 745-751.
7. Kern P. i wsp.: The expression of tumor necrosis factor in human adipose tissue. Regulation of obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest., 1996, 97, 1111-1116.
8. Kirchgessner T.G. i wsp.: Tumor necrosis factor α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J. Clin. Invest., 1997, 100, 11, 2777-2782.
9. Kokot F. i wsp.: Does leptin play a role in the pathogenesis of essential hypertension? Kidney Blood Pres. Res., 1999, 22(3), 154-160.
10. Leyva F. i wsp.: Hyperleptynemia as a component of a metabolic syndrome of cardiovascular risc. Arteriosclr. Thromb. Vasc. Biol., 1998, 18, 928-933.
11. Nyui N. i wsp. Tissue angiotensinogen gene expression induced by lipopolisacharide in hypertensive rats. Hypertension. 1997, 30, 859-867
12. Rywik S. i wsp.: Epidemiologia choroνb ukladu kra̧żenia. Program Pol-MONICA Warszawa. Kardiol. Pol., 1996, 44 (supl. II), 7-35.
13. Saghizadeh M. i wsp.: The expression of TNF alpha by human muscle. Relationship to insulin resistance. J. Clin. Invest., 1996, 97, 1111-1116.
14. Saito I. i wsp.: Serum leptin concentration in adolescents and adults with untreated essential hypertension. J. Hypertens., 1998, 16 (supl. 2), 156.
15. Van Itallie T.: The problem of obesity: health implications of overweight and obesity in the United States. Ann. Intern. Med., 1995, 103, 983-988.
16. Winkler i wsp.: Elevated serum TNF-α level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients. Diabetic Med., 1999, 16, 207-211.